In the News Scioto Biosciences, Inc. Announces Top-Line Results of SB-121 in a Phase Ib Trial in Patients Diagnosed With Autism Spectrum Disorder
Press Release Scioto Biosciences and Abigail Wexner Research Institute at Nationwide Children’s Hospital Receive a $2.3 Million Dollar Phase II SBIR Grant to Develop Novel Therapy
Press Release Scioto Biosciences, Inc. Announces First Patient Dosed in Phase Ib Study in Patients Diagnosed with Autistic Disorder
Press Release Scioto Biosciences Presents Single-dose, Single Strain Pre-clinical C. diff Intervention at American Academy of Pediatrics National Conference & Exhibition
Press Release Scioto Biosciences to Present at Microbiome Movement – Drug Development Summit in Boston
